Sage Journals: Discover world-class research

Retricted access

Other

First published 2008-3

Monitoring Clinical Trial Data Using an Unblinded Industry Statistician

Geraldine E. Baggs, Anand Seth, Jeffery S. Oliver [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2010-6

Effects of Participant Preferences in Unblinded Randomized Controlled Trials

Anna H. L. Floyd, Anne Moyer

Journal of Empirical Research on Human Research Ethics

Retricted access

Brief report

First published 2024-10-08

Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara [...]

Journal of Alzheimer’s Disease

Retricted access

Other

First published 2001-4

Internal Pilot Studies for Determining the Sample Size without Unblinding

Dietmar Zellner, Günter E. Zellner, Thomas Frankewitsch [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2018-8

Adjusting for bias in unblinded randomized controlled trials

AF Schmidt, RHH Groenwold

Statistical Methods in Medical Research

Retricted access

Other

First published 2010-1

Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm

Jitendra Ganju, Clapton Dias

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2013-2

Unblinding following trial participation: Qualitative study of participants’ perspectives

Natalie Armstrong, Clare J Jackson, Sarah McNicol [...]

Clinical Trials

Free access

Research article

First published 2016-5

Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes

David Ahn, Jeremy Pettus, Steven Edelman

Journal of Diabetes Science and Technology

Retricted access

Other

First published 2003-7

An Example of an Unblinded,Third-Party Interim Analysis for Sample Size Re-Estimation

Simon Kirby, Scott McBride, Lohita Puvanarajan

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2005-06

Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

Eleanor M Dinnett, Moira MB Mungall, Jane A Kent [...]

Clinical Trials

Search results